These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 9766667

  • 1. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
    Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT.
    Cancer Res; 1998 Oct 01; 58(19):4375-82. PubMed ID: 9766667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE, Youmell MB, Palayoor ST, Price BD.
    Clin Cancer Res; 1997 Jul 01; 3(7):1149-56. PubMed ID: 9815794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.
    Yoshida M, Hosoi Y, Miyachi H, Ishii N, Matsumoto Y, Enomoto A, Nakagawa K, Yamada S, Suzuki N, Ono T.
    Int J Radiat Biol; 2002 Jun 01; 78(6):503-12. PubMed ID: 12065055
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
    Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT.
    Cancer Res; 1999 Sep 01; 59(17):4375-82. PubMed ID: 10485486
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH, Feng Y, Fisher RH, Maloid S, Longo DL, Ferris DK.
    Mol Cancer Res; 2004 Jul 01; 2(7):417-26. PubMed ID: 15280449
    [Abstract] [Full Text] [Related]

  • 14. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.
    Sapkota GP, Deak M, Kieloch A, Morrice N, Goodarzi AA, Smythe C, Shiloh Y, Lees-Miller SP, Alessi DR.
    Biochem J; 2002 Dec 01; 368(Pt 2):507-16. PubMed ID: 12234250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts.
    Enns L, Murray D, Mirzayans R.
    Br J Cancer; 1999 Nov 01; 81(6):959-65. PubMed ID: 10576651
    [Abstract] [Full Text] [Related]

  • 19. The role of ATM and ATR in DNA damage-induced cell cycle control.
    Goodarzi AA, Block WD, Lees-Miller SP.
    Prog Cell Cycle Res; 2003 Nov 01; 5():393-411. PubMed ID: 14593734
    [Abstract] [Full Text] [Related]

  • 20. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.
    Price BD, Youmell MB.
    Cancer Res; 1996 Jan 15; 56(2):246-50. PubMed ID: 8542574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.